BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[ U.S. CDMRP – Peer-Reviewed Medical Research Program Technology
 /Therapeutic Development Award | Research Funding ]
DTSTART;VALUE=DATE:20200423
DTSTAMP:20260407T134246Z
UID:4b2b79ffa6e700ff58d21f6febd014100df86ec90b16e0053cebc104
CATEGORIES:Call for proposal
DESCRIPTION:Aim: Through the Congressionally Directed Medical Research Pro
 gram (CDMRP)\, the Department of Defense is announcing the Peer-Reviewed M
 edical Research Program (PRMRP) Awards. The PRMRP Technology/Therapeutic D
 evelopment Award is a product-driven award mechanism intended to provide s
 upport for the translation of promising preclinical findings into products
  for clinical applications\, including prevention\, detection\, diagnosis\
 , treatment\, or improvement of quality of life. The product(s) to be deve
 loped may be a tangible item such as a pharmacologic agent (drugs or biolo
 gics) or device\, or a knowledge-based product. Proof of concept demonstra
 ting the potential utility of the proposed product\, or a prototype/ preli
 minary version of the proposed product\, should already be established.\n\
 nRelevance to the healthcare needs of military Service members\, Veterans\
 , military beneficiaries\, and/or the American public is a key feature of 
 this award. Applications are required to include an explanation of how the
  proposed project has relevance to military health.\n\nAll applications fo
 r PRMRP funding must specifically address at least one of the Topic Areas 
 as directed by Congress and have direct relevance to military health. The 
 FY20 PRMRP Topic Areas are listed at the end of this announcement.\n\nFund
 ing:        max. $4’000’000\n\nDuration:      4 years\n\nEli
 gibility: Applicants from international organizations or institutions are 
 eligible to apply\, and there are no citizenship restrictions. PI applican
 ts must be independent investigators at or above the level of Assistant Pr
 ofessor (or equivalent).\n\nHow to Apply: Pre-applications are submitted t
 hrough the eBRAP platform. They should contain contact information\, a pre
 proposal narrative\, and a list of collaborators and key personnel as sugg
 ested on the platform. Full applications (by invitation) will be made via 
 a Grants.gov workspace. Full application packages can be downloaded from G
 rants.gov at any time.\n\nPre-Application Deadline: 23-Apr-2020\, 5:00 p.m
 . EST\nFull Application Deadline: 20-Aug-2020\, 11:59 p.m. EST\n\nGrants.g
 ov Funding Opportunity Number: W81XWH-20-PRMRP-TTDA\n\nFurther information
 \n\n	To see the program announcement\, navigate to the search page on Gran
 ts.gov and search for the Opportunity Number W81XWH-20-PRMRP-TTDA\n	For qu
 estions about the eBRAP or Grants.gov platforms\, contact the Research Off
 ice.\n\n\nFY20 Topic Areas\n\n\n	Arthritis\n	\n		Burn Pit Exposure\n		Chro
 nic Migraine and Post-Traumatic Headache\n		Congenital Heart Disease\n		Co
 nstrictive Bronchiolitis\n		Diabetes\n		Dystonia\n		Eating Disorders\n		Em
 erging Viral Diseases\n		Endometriosis\n		Epidermolysis Bullosa\n		Familia
 l Hypercholesterolemia\n		Fibrous Dysplasia\n		Focal Segmental Glomerulosc
 lerosis\n		Food Allergies\n		Fragile X\n		Frontotemporal Degeneration\n		G
 uillain-Barré Syndrome\n		Hemorrhage Control\n		Hepatitis B\n		Hydrocepha
 lus\n		Immunomonitoring of Intestinal Transplants\n		Inflammatory Bowel Di
 seases\n		Interstitial Cystitis\n		Metals Toxicology\n		Mitochondrial Dise
 ase\n		Musculoskeletal Health\n		Myalgic Encephalomyelitis/Chronic Fatigue
  Syndrome\n		Myotonic Dystrophy\n		Nutrition Optimization\n		Pancreatitis\
 n		Pathogen-Inactivated Blood Products\n		Plant-Based Vaccines\n		Polycyst
 ic Kidney Disease\n		Pressure Ulcers\n		Pulmonary Fibrosis\n		Resilience T
 raining\n		Respiratory Health\n		Rheumatoid Arthritis\n		Sleep Disorders a
 nd Restriction\n		Spinal Muscular Atrophy\n		Sustained Release Drug Delive
 ry\n		Vascular Malformations\n		Women’s Heart Disease\n	\n	\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR